Pneumococcal Vaccines Market size to Reach USD 12.33 Billion by 2031 as Adult Immunization Programs

Pneumococcal Vaccines Market Overview

According to analysis by Mordor Intelligence, the pneumococcal vaccines size is witnessing wider adoption across adult and geriatric populations as healthcare systems strengthen immunization coverage and disease prevention strategies.

The pneumococcal vaccines market size continues to expand as governments, healthcare providers, and international vaccine procurement programs focus on reducing the burden of pneumococcal infections. The market is also benefiting from the growing use of conjugate vaccines, increasing awareness regarding preventive healthcare, and stronger vaccine access across developing economies.

The approval of newer vaccine formulations for adults has added momentum to the pneumococcal vaccines market growth. Demand patterns are gradually shifting from pediatric-focused immunization toward broader adult vaccination schedules. At the same time, procurement support from international organizations is helping improve vaccine availability in lower-income countries.

Pneumococcal Vaccines Market Trends Driving Industry Expansion

Adult Vaccination Programs Supporting Pneumococcal Vaccines Market Growth

One of the major pneumococcal vaccines market trends is the increasing focus on adult and elderly immunization. Healthcare agencies are encouraging vaccination among adults with chronic illnesses and aging populations that face a higher risk of pneumococcal infections.

Broader Serotype Coverage Influencing Pneumococcal Vaccines Market Share

The pneumococcal vaccines market is also seeing rising interest in vaccines that provide broader serotype protection. Companies are focusing on conjugate vaccine development with expanded coverage to improve disease prevention outcomes.

Global Procurement Programs Expanding Industry Reach

International procurement programs and public health initiatives continue to improve vaccine access in developing regions. Support from multilateral healthcare organizations is helping countries maintain stable vaccine supply and improve immunization rates.

Regional Manufacturing Partnerships Supporting Supply Networks

Local manufacturing and fill-finish partnerships are becoming increasingly important in the pneumococcal vaccines market. Regional collaborations are helping improve supply reliability while supporting local healthcare infrastructure.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/pneumococcal-vaccines-market?utm_source=abnewswire

Pneumococcal Vaccines Market Segmentation Analysis

By Vaccine Type

• Pneumococcal Conjugate Vaccine (PCV)

• Pneumococcal Polysaccharide Vaccine (PPV)

By Product Type

• Prevnar

• Synflorix

• Pneumovax

• Other PCVs

By Distribution Channel

• Government Authorities

• GAVI and Multilateral Procurement

• Private and Retail Pharmacies

• Hospital-based Vaccine Clinics

By Age Group

• Pediatric Population

• Adult Population

• Geriatric Population

By Geography

• North America

• Europe

• Asia-Pacific

• Middle East and Africa

• South America

Competitive Landscape of the Pneumococcal Vaccines Industry

The pneumococcal vaccines industry includes global pharmaceutical companies with strong vaccine portfolios, established distribution capabilities, and ongoing product development programs. Companies are focusing on broader vaccine coverage, regional partnerships, and expanded immunization recommendations to strengthen their market position.

Key Players in the Pneumococcal Vaccines Market

• Pfizer Inc.

• CSL Ltd.

• Serum Institute of India Pvt. Ltd.

• GSK plc

• Merck & Co., Inc.

Conclusion

The pneumococcal vaccines market is expected to maintain stable growth as healthcare systems continue prioritizing disease prevention and immunization coverage. Increasing adult vaccination demand, broader vaccine availability, and continued public health support are contributing to positive market conditions.

The pneumococcal vaccines market size is also benefiting from stronger procurement frameworks, regional manufacturing partnerships, and growing awareness regarding pneumococcal disease prevention. While pricing concerns and supply chain challenges remain part of the pneumococcal vaccines industry environment, demand for preventive vaccination programs is expected to support long-term market expansion.

Industry Related Reports

Targeted Therapeutics Market:

The targeted therapeutics market is growing rapidly due to increasing prevalence of chronic diseases, rising demand for precision medicine, and advancements in biologics and monoclonal antibody therapies. Expanding oncology research and growing adoption of personalized treatment approaches are further driving market growth.

Get more insights: https://www.mordorintelligence.com/industry-reports/targeted-therapeutics-market?utm_source=abnewswire

Idiopathic Short Stature Market size:

The idiopathic short stature market is expected to reach USD 2.80 billion by 2031, growing at a CAGR of 8.34% during the forecast period. Increasing awareness about growth disorders, advancements in hormone therapies, and rising pediatric healthcare investments are supporting market expansion.

Get more insights: https://www.mordorintelligence.com/industry-reports/idiopathic-short-stature-market?utm_source=abnewswire

Uterine Serous Carcinoma Market share:

The uterine serous carcinoma market is projected to reach USD 4.93 billion by 2031, registering a CAGR of 6.20% during the forecast period. Rising incidence of gynecological cancers, growing focus on targeted cancer therapies, and advancements in diagnostic and treatment options are driving market growth.

Get more insights: https://www.mordorintelligence.com/industry-reports/uterine-serous-carcinoma-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

[email protected] https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/